Clinical Trial Update: Selumetinib and Olaparib in Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of selumetinib and olaparib in various solid tumors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Digestive System Cancer
• Gynecologic Cancer
• Male Genital Tract Cancer
• Thyroid Cancer

Drugs mentioned

• Olaparib (Olaparib)
• Selumetinib (selumetinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Status: ACTIVE_NOT_RECRUITING